demonstrated increased deposition of [3H]fluoromisonidazole in experimental myocardial ischemia.7
[18F]Fluoromisonidazole has been successfully synthesized, and preliminary studies using positron emission tomography (PET) in dogs have shown enhanced regional deposition of this tracer in ischemic myocardium. 8, 9 To study the relation between myocyte Po2 and fluoromisonidazole uptake, we measured the uptake and retention of [3H]fluoromisonidazole in isolated adult rat myocytes, because this model allows more precise control of cellular Po2 than can realistically be achieved in vivo. The results indicate a direct relation between reduced cellular P02 and enhanced fluoromisonidazole uptake in cardiac myocytes.
Materials and Methods
Isolated, calcium-tolerant adult rat myocytes were obtained by collagenase dissociation.10 Hearts were rapidly excised, mounted on a Langendorff apparatus, and perfused for 1 minute at constant pressure (85 mm Hg) with calcium-free modified minimum essential medium (GIBCO Laboratories, Grand Island, N.Y.) supplemented with insulin, taurine, and creatine. All buffers were prewarmed to 370 C, equilibrated with 95% 02-5% CO2 at pH 7.4, and adjusted for osmolarity. After the initial perfusion cleared blood from the heart, perfusion continued for another 15 minutes with medium containing 0.06% Martin et al Fluoromisonidazole: A Metabolic Marker 241 crude collagenase and 0.03 mM calcium. The hearts were then removed from the cannula and minced with razor blades; individual cells were released by gentle pipetting and collected by centrifuging the suspension at 350 rpm for 2 minutes. The pellets were washed with collagenase-free medium, and calcium chloride was added gradually until a concentration of 1 mM was achieved. After being allowed to equilibrate for 45 minutes, the final pellet was resuspended, a cell count was performed, and the cells were diluted to approximately 200,000 cells/ml. Contour Permanox tissue culture dishes (Miles Scientific, Naperville, Ill.), precoated with laminin solution (8 ,ug/ml), were plated with 1.25 ml of the cell suspension. Placement of a plastic ring on the plates before plating allowed attachment of cells only in the center of the dish. This was done to minimize differences in the depth of the medium covering the cells due to meniscus effects at the periphery. The medium was replaced with fresh medium containing 100 mg/ml bovine serum albumin, and the cells were kept overnight at 370 C in 95% room air-5% CO2. Studies were performed 24 hours after isolation.
After overnight incubation, the cells were rinsed and covered with a thin layer of medium (1 ml per 60-mm dish) containing ['H]fluoromisonidazole (50 ,uM) . The drug was synthesized as previously described" and stored in a dilute solution in absolute ethanol at 50 C to minimize radiolytic decomposition; its radiochemical purity by high-performance liquid chromatography was greater than 99%. The cells were exposed to the desired oxygen conditions using the thin film culture techniques of Koch.12 The dishes were placed in airtight aluminum chambers connected to a manifold system that allowed serial evacuation at reduced pressure and flooded the chambers with a specified premixed gas mixture. Evacuation at reduced pressure causes rapid outgassing of residual cellular oxygen, and the thin medium layer allows rapid equilibration with the replacement gas mixture. To scavenge any small amounts of oxygen, a separate dish containing sodium dithionite was added to each anoxic chamber. Anoxia was verified at the end of incubation by noting the maintenance of the reducing capacity of the sodium dithionate solution, namely, the ability to rapidly decolorize methylene blue at the end of each experiment. Independent studies12 have shown that this procedure does not damage cells. Each chamber was equilibrated with one of the following mixtures: 1) 95% room air-5% CO2 (normoxic), 2) 5,000 ppm 02-5% CO2-balance N2 (hypoxic), or 3) 5% CO2-95% N2 (anoxic); the chamber was kept at 370 C for specified times up to 180 minutes.
An Cell numbers per dish were determined by counting 13 premarked high-power fields and correcting for the cell attachment area. The plates were scraped, and the cell material was placed in scintillation vials along with the scintillation cocktail (Instagel, Packard Instrument Co., Inc., Downers Grove, Ill.) for liquid scintillation counting. Counting efficiency was determined by the external standards ratio, and the drug uptake data are expressed as picomoles per 105 cells. Cell-free dishes were included in each experiment to account for background due to nonspecific adherence of the drug to the laminin. Several plates of cells exposed to 180 minutes of anoxia were fixed and embedded in epoxy; ultrathin sections were prepared for examination of cell morphology by electron microscopy.
To assess fluoromisonidazole uptake during less severe hypoxia and to relate uptake to indicators of cell injury, cells were incubated under normoxic, hypoxic (5,000 ppm 2, -3.5 mm Hg), or anoxic conditions for 60 or 180 minutes. At the designated times, the dishes were removed, and the medium was collected and immediately centrifuged and stored at 00 C for subsequent determination of creatine kinase (CK) activity. CK activity was measured spectrophotometrically and expressed as units per 105 cells. Total cell counts were determined as before. In addition, the percentage of myocytes retaining normal rodlike morphology was determined, providing an additional indicator of cell injury. Tritium activity was determined as before.
Additional experiments were performed to study whether metabolic trapping of fluoromisonidazole is reversible. Cells were prelabeled with ['H]fluoromisonidazole under anoxic conditions for 2 hours as before, and then they were rinsed four times and covered with drug-free medium. One group of dishes was processed immediately to determine tritium content of both cells and medium. Two additional groups were reincubated for an additional 3 hours under either normoxic or anoxic conditions. Cell number and percent rods were determined, and cell and medium samples were counted for tritium as before. In four dishes, 0.1 ml medium was removed for scintillation counting and replaced with 0.1 ml cold medium at 20-minute intervals during the 3-hour incubation to determine the time course of efflux of radioactivity from the cells. Differences in percent rods, CK release, and ['H]fluoromisonidazole uptake between experimental groups were evaluated using the Kruskal-Wallis test.
Results
The isolation and plating procedures yielded 22.9 x 10' ± 6.2 x 10' calcium-tolerant cells/dish, of which 85% retained the normal rod-shaped morphology. As quiescence, Trypan blue dye exclusion, and contraction with external stimulation. Examination of rodshaped myocytes by electron microscopy showed that exposure to the evacuation procedure and 21% oxygen resulted in only minor vacuole formation. Myocytes exposed to anoxia had intact sarcolemma, but blebbing and pinching off of membrane segments were observed. Intracellular vacuoles were observed throughout the cell, and there were mitochondria with giant cristae formation and deposition of dense granules. The actin-myosin contractile system had a normal appearance, and there was no evidence of contraction band formation. These changes are consistent with hypoxic damage, but the absence of contraction band necrosis suggests that these changes are reversible. The lack of significant ultrastructural damage in cells exposed to 21% oxygen suggests that the incubation procedure did not cause myocyte injury. Figure 1 shows the time course Table 1) .
These experiments clearly demonstrate a general relation between fluoromisonidazole uptake and the severity of hypoxia. However, an exact relation between drug uptake and cellular Po2 cannot be defined. The procedures used ensure rapid oxygen equilibration between the gas phase in the aluminum chambers and the thin layer of medium overlying the cells. However, it is probable that there are small oxygen gradients between the unstirred layer of medium immediately adjacent to the cells and the cell interior where drug trapping occurs.14 Thus, although the presence of 5,000 ppm 02 in the chamber inhibited binding by approximately 50%, the actual cellular P02 was in all likelihood somewhat less.
The exact biochemical mechanism responsible for trapping of fluoromisonidazole in hypoxic heart cells is uncertain. A likely mechanism involves formation of reduced metabolites, including radical intermediates, via the action of intracellular nitroreductases.15 It is hypothesized that one or more metabolites are trapped either by binding to intracellular macromolecules or by virtue of having a lower cell membrane permeability than the parent compound. Oxygen is thought to inhibit this process via oxidation of the one-electron reduction product with reformation of the parent drug in a "futile" cycle. 16 These experiments also demonstrate an oxygeninsensitive efflux of fluoromisonidazole and/or labeled metabolites from the myocytes. Thus, net uptake of this drug reflects both an oxygen-sensitive trapping mechanism and a release process that is relatively independent of Po2. In these studies, the rate of release was approximately 15% of the net uptake rate under anoxic conditions. Although this should not impose serious limitations on the use of this drug to image hypoxic myocardium, further studies are needed to define the relative magnitude of both uptake and release in vivo.
The data implicate cellular hypoxia as the principal cause for enhanced fluoromisonidazole deposition in ischemic myocardium.7-9 Ischemia is characterized not only by reduced tissue Po2 but also by excessive local accumulations of metabolic end products, and pH may fall to 6.0.17 However, in the current studies, the incubation medium can be considered a limitless "sink" that provides a constant supply of oxygen and other metabolic substrates and prevents excessive proton accumulation. This is evidenced by a fall in pH to only 7.32 . Therefore, it is unlikely that severely ischemic conditions are a prerequisite for binding. solution, and with our own in vivo studies showing increased fluoromisonidazole deposition in regions of myocardium that were only mildly underperfused, with flows greater than 60% of normal.9
Another conclusion from these studies is that enhanced drug uptake can occur, at least in this model, at sublethal levels of hypoxia. The moderate hypoxia induced by incubation with 5,000 ppm 02 resulted in no changes in cell viability, as measured by loss of rod-shaped morphology, and no significant release of CK. In previous studies, cytosolic enzyme release has been shown to precede the development of irreversible cell injury.18 The absence of contraction band necrosis by electron microscopy is further evidence that the hypoxic injury in our studies was reversible. Enhanced uptake of fluoromisonidazole in the absence of irreversible cell injury supports the hypothesis that PET imaging of [18Flfluoromisonida-zole will provide a positive image of hypoxic but viable myocardium.
The data have several additional implications regarding the use of [18F]fluoromisonidazole for hypoxia imaging. First, fluoromisonidazole uptake is rapid relative to the radioactive half-life of fluorine 18 (1.8 hours). Second, the uptake rate reflects not only the presence of hypoxia but also the severity. The latter supports the notion that PET imaging of [18F]fluoromisonidazole will provide quantitative information regarding regional myocardial oxygenation. Third, since net accumulation of this tracer reflects both oxygen-sensitive uptake and oxygeninsensitive efflux, modeling approaches to analysis of imaging data will need to consider both processes.
In conclusion, hypoxia-dependent uptake of the 2-nitroimidazole fluoromisonidazole is the basis for a unique strategy for detecting cellular hypoxia and thus may provide important information regarding myocardial metabolism. As an experimental tool, it may be useful for studying the physiology of oxygen delivery and utilization in the heart. PET imaging of [13Flfluoromisonidazole may allow clinical application of this compound. Noninvasive detection of viable hypoxic myocardium may be particularly useful in selecting patients for revascularization procedures.
